Feasibility, Acceptability, and Preliminary Efficacy of a Mobile App (nOCD) for OCD
NCT ID: NCT03476902
Last Updated: 2020-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2017-10-27
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of a Self-guided Mobile Application in Improving Obsessive Compulsive Disorder Symptoms
NCT06202677
Waitlist-Control Trial of Smartphone CBT for Obsessive-Compulsive Disorder (OCD)
NCT03767491
Personalized Computerized Inhibitory Control Training for OCD
NCT02378896
Brief Anxiety Sensitivity Treatment for Obsessive Compulsive Symptoms
NCT02635178
Using Personalized Assessments in the Treatment of Childhood OCD
NCT06407648
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integrated Mobile Treatment
Individuals will receive 4 introductory sessions with a therapist followed by weekly phone calls. Participants will utilize nOCD application to assist with treatment protocol adherence.
Therapist assisted mobile intervention
Individuals will receive 4 introductory sessions with a therapist followed by weekly phone calls. Participants will utilize nOCD application to assist with treatment protocol adherence.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapist assisted mobile intervention
Individuals will receive 4 introductory sessions with a therapist followed by weekly phone calls. Participants will utilize nOCD application to assist with treatment protocol adherence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-65
* Not currently receiving psychotherapy focused on OCD symptoms, and no EX/RP within the past 12 weeks
* For those currently on medication: On a stable dose of psychiatric medication (for at least 12 weeks)
* Capacity to provide informed consent
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helen Blair Simpson
Research Chief
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marina Gershkovich, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
New York State Psychiatric Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York State Psychiatric Institute
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gershkovich M, Middleton R, Hezel DM, Grimaldi S, Renna M, Basaraba C, Patel S, Simpson HB. Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects. Behav Ther. 2021 Mar;52(2):394-405. doi: 10.1016/j.beth.2020.05.001. Epub 2020 May 11.
Related Links
Access external resources that provide additional context or updates about the study.
Center for OCD \& Related Disorders Webpage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7572
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.